Cynthia Mazareas > WilmerHale > Boston, United States > Lawyer Profile
WilmerHale Offices
60 STATE STREET
BOSTON, MA 02109
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Cynthia Mazareas
Work Department
Capital Markets Corporate Governance and Disclosure; Cross-Border Transactions; Emerging Company and Venture Capital; Life Sciences; Mergers and Acquisitions
Position
Partner
Career
Cynthia Mazareas brings more than 25 years of experience and a passion for medical and scientific innovation to her role as a trusted adviser to companies in the life sciences industry. She provides ongoing, strategic business counsel to boards, management teams and in-house counsel, representing high-growth private and public companies in corporate matters, complex business transactions, including public offerings and venture capital financings, and corporate governance, SEC, stock exchange and Sarbanes-Oxley compliance. Ms. Mazareas is named in Best Lawyers in America for biotechnology and life sciences, has been named a Life Sciences Star by LMG Life Sciences and was recommended for The Legal 500 United States for capital markets: equity offerings – advice to issuers.
Ms. Mazareas has counseled a range of public life sciences companies throughout all stages of growth, including Agios Pharmaceuticals, AVEO Pharmaceuticals, Beam Therapeutics, Cue Biopharma, Curis, IMARA, Infinity Pharmaceuticals, Schrödinger, Syros Pharmaceuticals, Translate Bio and Xilio Therapeutics. Her emerging growth private company clients include Auron Therapeutics and Volastra Therapeutics.
Clients rely on her combination of industry knowledge, legal experience and business acumen. One told Best Lawyers that she gives “great practical advice.” Another told Chambers and Partners, “I think very highly of Cynthia Mazareas, in life sciences in particular. She’s someone who truly does live the life of her clients. She’s been doing this for a long time and she understands a great deal of the challenges that smaller companies face and is very adept at trying to help folks work through the types of challenges encountered by those companies.”
Ms. Mazareas’ involvement with the biopharmaceutical industry predates her legal career: she began her professional life in healthcare, a background that gives her insight into the real-world concerns that shape the landscape for such companies.
Community Involvement
Ms. Mazareas’ engagement with the life sciences industry extends to her community involvement. She serves on the Board of Directors for Life Science Cares, a nonprofit organization that brings together companies in the life sciences industry to eliminate the impact of poverty in the greater Boston area, and chairs the organization’s Nominating and Governance Committee. She was also a member of the Board of Directors of Prize4Life, a nonprofit that works to find treatments and cures for ALS. She and her husband received the Courage Award from Prize4Life in 2014.
Ms. Mazareas has also served as a member of the Board of Trustees of Shore Country Day School and as chair of its Diversity Committee and a member of its Committee on Trustees.
Professional Activities
Ms. Mazareas is an author and frequent speaker on corporate transactions, governance and other matters relating to life sciences and biotechnology companies.
Ms. Mazareas is a member of the Society of Corporate Secretaries & Governance Professionals and serves on the advisory committee of the Eastern New England Chapter. She is also a member of the Board of Directors of the Greater Boston Chamber of Commerce.
She is a member of the Massachusetts Biotechnology Council, the Massachusetts Bar Association, the Boston Bar Association, and the Massachusetts Black Women Attorneys Bar Association. She also plays an active role at WilmerHale as a member of the firm’s Women’s Leadership Initiative, and Hiring Committee.
Memberships
Bar Admissions:
Massachusetts
Other Organizations:
Boston Bar Association
Massachusetts Bar Association
Education
Georgetown University Law Center , J.D. (1993)
Boston University , B.S. (1985)
Lawyer Rankings
United States > Finance > Capital markets: equity offerings
WilmerHale has a notable record in representing growth companies in IPOs and other equity offerings, particularly those in the life sciences and technology sectors. In 2023, it continued to advise issuers in mid-market public offerings and follow-on offerings, especially those by life sciences issuers. Boston partners Stuart Falber and Cynthia Mazareas are noted for life sciences sector offerings with Lisa Firenze and Brian Johnson being key figures in New York. Caroline Dotolo is another ‘go to‘ partner in Boston.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Antitrust > Cartel
- International trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Industry focus > Education
- Industry focus > Education
- Industry focus > Education
- Intellectual property > Patents: licensing
- Industry focus > Native American law
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Outsourcing
- Government > State attorneys general
- Media, technology and telecoms > Technology transactions
- International trade > Trade remedies and trade policy
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: equity offerings
- M&A/corporate and commercial > Corporate governance
- International trade > Customs, export controls and economic sanctions
- Government > Government contracts
- Government > Government relations
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (International Trade Commission)
- Tax > US taxes: non-contentious
- Finance > Commercial lending
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Dispute resolution > Corporate investigations and white-collar criminal defense